Artwork

Content provided by MMC Ventures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MMC Ventures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S04E02. Accelerating the future of personalised medicine

32:33
 
Share
 

Manage episode 387930476 series 2112781
Content provided by MMC Ventures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MMC Ventures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
MMC Principal, Charlotte Barttelot, leads our focus on data-driven health investments. In this episode, she interviews Patrick Short, founder and CEO of Sano Genetics - an MMC portfolio company that connects patients directly with biotech and pharmaceutical companies, accelerating research on rare and chronic diseases. The dramatic reduction of cost and time to sequence the human genome has led to the acceleration of personalised medicine. Charlotte and Patrick discuss the impact this has on the evolution of the drug development process, the change in attitude to the use of personal data, and how important the move towards greater trust and transparency in the industry is.
  continue reading

31 episodes

Artwork
iconShare
 
Manage episode 387930476 series 2112781
Content provided by MMC Ventures. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MMC Ventures or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
MMC Principal, Charlotte Barttelot, leads our focus on data-driven health investments. In this episode, she interviews Patrick Short, founder and CEO of Sano Genetics - an MMC portfolio company that connects patients directly with biotech and pharmaceutical companies, accelerating research on rare and chronic diseases. The dramatic reduction of cost and time to sequence the human genome has led to the acceleration of personalised medicine. Charlotte and Patrick discuss the impact this has on the evolution of the drug development process, the change in attitude to the use of personal data, and how important the move towards greater trust and transparency in the industry is.
  continue reading

31 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide